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University of Perugia, Perugia, ItalyA B S T R A C TObjective: This article estimated the causal effect of quitting smoking
on body weight gains in the United Kingdom to evaluate whether
savings in health costs deriving from smoking prevention and its
related diseases are greater than the costs associated with increased
obesity.Methods: We used a longitudinal data set extracted from two
waves (2004–2006) of the British Household Panel Survey, which
includes information on smoking and a large number of sociodemo-
graphic variables. We modeled the effect of quitting smoking on
body weight accounting for heterogeneous responses from individ-
uals belonging to different clinical classes of body mass index (BMI)
(i.e., overweight and obese individuals). National Health Service
costs associated with smoking were then used to implement a
cost-beneﬁt analysis, comparing the advantages of smoking reduc-
tions with the costs associated with increased obesity. Results: The
BMI was found to increase by 0.26 points for quitters compared withee front matter Copyright & 2015, International S
r Inc.
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oni@unipg.it.
ndence to: Luca Pieroni, Department of Political Scthose who continued to smoke. The estimated BMI increase was
larger for overweight (0.49 points) and obese (0.76 points) people.
This result does not change when different control groups are
examined. From an economic perspective, the National Health
Service cost reductions attributable to quitting smoking were
£156.81 million whereas the lost beneﬁt for unintended increases
in body weight was £24.07 million. Conclusions: This article
found that the health beneﬁts associated with quitting smoking
are greater than the costs associated with increased overweight and
obesity.
Keywords: Obesity, quitting smoking, BHPS dataset, health care costs
and beneﬁts.
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In the last few decades, obesity has become a substantial risk
factor for a number of severe and chronic diseases that constitute
the main causes of death, including heart disease, strokes, some
types of cancer, and other serious life-shortening conditions such
as type 2 diabetes. Similar patterns of the prevalence of over-
weight and obesity are shown in the United States and Europe,
although in the old continent they reach a lower absolute
level [1].
In the United Kingdom, obesity has constantly risen by 8 to 9
percentage points over the last 15 years, sex trends being
similar. The burden on the National Health Service (NHS) asso-
ciated with the excess weight was estimated to have increased in
the period 1998 to 2006 from 1.5% to 2.6% of total health
expenditure. Estimates by the NHS forecast that the cost to the
service, directly attributable to obesity, may rise to £5.3 billion
by 2025.
Over the last two decades, another clearly evident trend
that has pervaded Western countries has been the decline in
the rate of smoking. Simultaneous examination of smoking
and body weight trends has led to mixed evidence on thisrelationship [2–5], although some recent works have estab-
lished the existence of a signiﬁcant negative causal nexus
between smoking and body weight [6–10]. This result is also
supported by the medical literature, which shows how smok-
ing reductions imply changes in metabolic rates and eating
habits, leading to the unintended consequence of weight gains
[11–13]. These studies, however, never analyzed whether the
savings in health care costs associated with quitting smoking
were larger or smaller than the increased costs required in
treating obesity.
In this article, we sought to contribute to this literature by
comparing social costs due to increased obesity with beneﬁts
from quitting smoking in the United Kingdom. To achieve this
aim, we evaluated the heterogeneous effects of quitting smoking
for individuals belonging to various body mass index (BMI)
clinical classes. We used a longitudinal data set extracted from
two waves (2004–2006) of the British Household Panel Survey
(BHPS) that includes information on smoking and a large number
of sociodemographic variables. We exploited the fact that we
observed a random sample of the population of smokers in two
periods, in which some subjects made the transition from
smoking to nonsmoking status. Our model allowed us to includeociety for Pharmacoeconomics and Outcomes Research (ISPOR).
ience, University of Perugia, Via Pascoli 20, Perugia 06123, Italy.
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In this way, we could estimate the effect of changes in smoking
habits on BMI for overweight and obese individuals, which are of
particular interest for policymakers.
Our empirical strategy used a difference-in-differences (DID)
approach to control for time-invariant unobservable con-
founders and used various “control groups,” in addition to
the natural control group of “smokers,” to account for other
possible sources of bias related to reverse causality or omitted
variables.
The article is organized as follows. First, we document a
signiﬁcant increase in body weight for quitters. Although point
estimates are not very large in magnitude, weight is found to
increase particularly in obese individuals. Second, sensitivity
analysis generally conﬁrms these ﬁndings when various control
groups are used to account for various sources of bias. Third,
results from a cost-beneﬁt analysis indicate that quitting smok-
ing implies much larger savings in health costs than the costs
required in treating increased obesity.Estimates of Health Care Costs Generated by Smoking
and Obesity in the United Kingdom
There are very many works estimating the NHS costs of obesity
and smoking in the United Kingdom, and so choosing which
source to adopt to obtain reliable estimates is more difﬁcult.
Concerning the economic costs of smoking-related ill health in
the United Kingdom, we follow the systematic review by Allender
et al. [14]. The authors compared studies published between 1997
and 2007 and calculated the burden of ill health due to smoking
in each country of the United Kingdom. In particular, population-
attributable fractions for smoking-related diseases from the
World Health Organization’s Global Burden of Disease Project
were applied to NHS cost data to estimate direct ﬁnancial costs.
After analyzing more than 4000 articles, the above authors
concluded that 109,164 deaths were attributable to smoking-
related disease in 2006, which were responsible for £5.17 billion
in health care costs (5.5% of total health care costs).
In our assessment of weight excess in the United Kingdom,
we preferred to use the study by The House of Commons Health
Select Committee [15]. That study estimated that the total cost
attributable to obesity (i.e., for individuals with a BMI of >30)
was about £3340 million to £3724 million in 2002. About 30% of
total costs were due to the direct health care costs of treating
obesity and its consequences, including general practitioner
consultations, in-patient and day case admissions, outpatient
attendance, and the cost of drugs. The costs of treating obesity
and its consequences were 2.3% to 2.6% of the NHS expenditure.
The greater part of these costs, however, was attributable to
treating the consequences of obesity, rather than obesity itself,
including cardiovascular diseases, type II diabetes, stroke,
angina, osteoporosis, and various types of cancers. There were
also obesity-related costs generated by lost earnings (i.e., lost
potential national output), which could be directly attributed to
obesity. These were reported by McCormick and Stone [16] to be
in the range of £2350 million to £2600 million, of which about
50% were attributable to premature mortality due to obesity and
the other 50% to consequences of certiﬁed diseases related to
obesity.
In this article, we used only direct costs to compare social
costs due to increased obesity, with beneﬁts from quitting
smoking, because we did not have information about smoking
costs generated by lost earnings and also because, as suggested
by Morris [17], estimates of indirect costs connected with lost
earnings are largely underestimated.Methods
Data
The data set used in this work were extracted from the multi-
purpose BHPS, which reports information at both household and
individual levels for a representative sample of the UK popula-
tion. The original sample was composed of 5,500 households and
10,300 individuals, drawn from 250 areas of England, and was
subsequently enlarged to include Scotland and Wales in 1999 and
Northern Ireland in 2002. The data set has 18 waves: the ﬁrst
survey was conducted in 1980, but, for our purposes, we used a
sample of two waves, the 14th and 16th waves, conducted,
respectively, in 2004 and 2006 because data on height and weight
were also collected. Although these two anthropomorphic char-
acteristics were self-reported, the potential measurement errors
over time are limited by the reduced time span covered by our
sample (see, e.g., Shiely et al. [18]). We selected a balanced panel
of 13,320 individuals for whom we had information about smok-
ing habits and height and weight, which allowed us to calculate
their BMI. Attrition is unlikely to be a problem in our data because
the number of individuals who dropped out between the above
two waves was quite limited. (The original sample was composed
of 26,640 individuals, a number that later fell to 26,469. We also
tested for differences between covariate distributions before and
after balancing, and these were found not to be relevant. The
tables are available from the authors upon request.) In fact,
because nonresponse rates between 2004 and 2006 were very
low, attrition problems were not likely to arise.Model Structure
We examined a benchmark model in which BMIit is the contin-
uous measure of the BMI of an individual i at time t, and in which
some fraction of the population reduces its cigarette consump-
tion (e.g., nonrandom treatment). That is, individuals were
observed in the pretreatment period t¼0 and in the posttreat-
ment period t¼1, during which Dit¼1 if an individual was
exposed to the treatment between t¼0 and t¼1 and Dit¼0 if
not (control group).
From a theoretical point of view, we assumed that subjects
“treated” in t¼1 decided to reduce their smoking up to the
extreme case of “zero cigarettes smoked” (i.e., quitting), a sit-
uation that is of great interest in the health economics literature
[19,20]. With these premises, estimation of the causal effect of
smoking on BMI was hindered by the presence of indigeneity, due
to unobservable characteristics or reverse causality. To solve this
problem, part of the literature uses a DID strategy with panel data
(see, e.g., Baum [6] and French et al. [21]), which accounts for
individual unobservable time-invariant characteristics affecting
cigarette consumption and weight differently for treatment and
control groups.
In view of the panel nature of our data set, we also adopted
the DID approach and controlled for indigeneity by deﬁning
different control groups, to take account of the bias induced by
reverse causality or time-varying unobservable characteristics
(for more details, see the next section). We assumed that the
outcome of interest (i.e., BMI) was generated through a compo-
nent of variance process. A sufﬁcient condition to identify the
effect of smoking status changes is that selection for treatment,
conditional on covariates, does not depend on individual tran-
sitory shocks. Because overweight and obese individuals are of
great interest to policymakers, because preventing weight excess
produces both signiﬁcant gains in terms of health and reductions
in terms of costs for treating their related illnesses, we consid-
ered possible heterogeneous treatment effects across BMI clinical
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speciﬁcation is expressed by the following equation:
BMIit¼μþ
X4
h¼1
ηhðD BÞihþ
X4
h¼1
δhðT  BÞthþ
X4
h¼1
βhðD T  BÞithþ
XJ
j¼1
πjXjitþεi,t ð1Þ
where Bh, with h ranging from 1 to 4, is a categorical variable
representing individuals classiﬁed as underweight (i.e., BMI o
19), normal weight (i.e., BMI Z 19 and BMI o 25), overweight (i.e.,
BMI Z 25 and BMI o 30), or obese (i.e., BMI Z 30) in 2004. Di is a
dummy variable indicating treatment status for each individual i.
We deﬁne quitters as treated, whereas control groups are dis-
cussed in next sections. Tt is a time dummy variable that
indicates data collected in 2004 and 2006, respectively. The
coefﬁcient ηh associated with Di captures any preexisting differ-
ence among treatment and control groups and for each BMI class;
the coefﬁcient δh associated with Tt is a proxy for unobserved
variables that may affect BMIs of treatment and control groups.
The heterogeneous effect of quitting across BMI classes is
captured by βh, and estimated as the interaction between Di, Tt,
and Bh, which represents the DID estimate of the average treat-
ment effect (ATE) for group h in the two observed periods:
βDIDh ¼ E½BMIh01jXE½BMIh00jX
E½BMIh11jXE½BMIh10jX,
ð2Þ
where for the sake of simplicity we indicate with BMIhdt the BMI of
individuals with treatment status d interviewed at time t and for
clinical threshold h.
Identiﬁcation of Average Treatment Effects
We start our discussion on model identiﬁcation by deﬁning the
following treatment and control groups.
D1. Treated group of smokers who quit smoking (TGQ):
individuals who were smokers in 2004 and became nonsmokers
in 2006.
D2. Control group of smokers (CGS): individuals who were
smokers in 2004 and remained so in 2006.
In our model, quitters (i.e., treated individuals) were deﬁned
by a question asked in the BHPS about smoking status. The
speciﬁc question is posed as “Do you smoke cigarettes?” and was
recorded as a dichotomous variable. (The question posed in this
way represents a limitation for our study, because it does not
provide information about the frequency of smoking. Smoking
and quitting smoking are chaotic unstable processes, and many
attempts at quitting, e.g., are unplanned or spontaneous and
many fail almost immediately, as suggested by West [22].) The
BHPS also contains another question measuring smoking habits,
which provides information about how many cigarettes the
respondent usually smokes per day. In this article, we decided
to use only the ﬁrst question, about smoking participation,
because we were more interested in the effects of quitting, rather
than of smoking reduction. In order not to include subjects with
unusual smoking behaviors in treatment or control groups, we
used BHPS waves from 1999 to 2003 to reconstruct individual
smoking histories. We then excluded from the sample those
individuals who stated they were nonsmokers between 2004 and
2006, but who had been smokers between 1999 and 2003, and also
those who stated they had been smokers between 1999 and 2003
but who were nonsmokers between 2004 and 2006.
Our evaluation strategy assumes that weight variations
between 2004 and 2006 for TGQ individuals were affected by
quitting smoking and by a spontaneous dynamic (i.e., time-
speciﬁc component), whereas individuals who continued to
smoke (CGS) were affected only by the spontaneous dynamic.According to Cawley et al. [23], however, smoking habits are
inﬂuenced by body weight if smokers do not quit because they
are afraid of putting on weight. In this case, estimates of the
relationship between smoking and body weight are biased by
reverse causality. In addition, comparing TGQ with CGS may
produce biased estimates because the estimated weight variation
for the CGS is biased downward and consequently the estimated
ATEs are biased upward.
We evaluated the magnitude of this effect by deﬁning two
control groups. The ﬁrst also comprised nonsmokers in the
smokers’ control group (from this control group we excluded
nonsmokers who started smoking in 2006, irrespective of
whether they were or were not ex-smokers in 2004. We anticipate
that the dimension within our sample [2.04%] is negligible for our
estimates), that is, control group of smokers and nonsmokers
(CGALL), whereas the second comprised only nonsmokers, that
is, control group of nonsmokers (CGNS). Both groups were
composed of individuals who kept their cigarette consumption
stable and who, in principle, were not affected by reverse
causality, like the CGS, because their weight did not affect their
smoking decisions. We formally deﬁned:
D3. CGALL: individuals who were smokers or nonsmokers in
2004 and remained so in 2006.
D4. CGNS: individuals who were nonsmokers in 2004 and
remained so in 2006.
Because treatment was not randomly assigned in our data set,
treated and control groups also differed according to time-
varying unobserved factors related to smoking and weight deci-
sions. In this case, the presence of unobserved heterogeneity may
have caused our baseline estimates, comparing treatment groups
(i.e., TGQ) with CGS, to be biased downward. In fact, quitters
turned out to be generally more concerned about their health and
more oriented toward the future, as discussed by McCaul et al.
[24], and their decision to quit smoking may thus be seen as part
of a more general attitude aimed at improving health—for
example, also by reducing weight in obese people. The presence
of these individuals in TGQ may have biased downward not only
the estimated weight variation but also the estimated ATEs.
To take this aspect into consideration, we made up a new
control group composed of individuals who were smokers in 2004
and 2006, but who quit in 2008. That is, the BMI variation of “next
period” quitters was considered as the most appropriate control
group for the BMI variation of TGQ because they had the most
similar unobservable characteristics according to their future
health behavior. A similar strategy was proposed and applied to
the job market by Del Bono and Vuri [25]. Formally, our new
control group was deﬁned as follows:
D5. Control group of “next period” quitters (CG08): individuals
who were smokers in 2004 and 2006, but who quit in 2008. (We
used BHPS waves from 1999 to 2008 to reconstruct individual
smoking histories. We then excluded from the sample those
individuals who stated they were nonsmokers between 2006 and
2008, but who were smokers between 1999 and 2005 and also
those who stated they were smokers between 1999 and 2005 but
who were nonsmokers between 2006 and 2008.)
To obtain estimates as precise as possible about the effects of
quitting smoking on BMI, we exploited the BHPS panel structure.
In particular, we eliminated from CGNS and CGALL individuals
who were smokers between 1999 and 2004 and fell from being
CGS (CGNS or CGALL) individuals who were smokers (never
smokers) in 2004 and who changed their smoking status in
2005, but who stated they were smokers (never smokers) in 2006.
Covariates
We exploited the ample information available in the BHPS to take
into account a full set of observable individual characteristics in
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variant variables were introduced into the models as variations
between waves, as in French et al. [21]. However, we exploited the
fact that for most variables, other than BMI, we also had
information from other BHPS waves to calculate variations
between t and t – 1 and between t – 1 and t – 2. (Observations
of individuals with a BMI of >40 or o15 were dropped from our
sample. Note that weight in the BHPS is recorded as pre-
pregnancy weight, whenever relevant.) Matrix X of covariates is
composed of time-invariant covariates: sex, ethnic group mem-
bership, age, net income, education, and country dummies. Then,
we included a set of time-variant sociodemographic covariates,
reporting in our models both their absolute level and variations
between t and t – 1 and between t – 1 and t – 2, related to physical
activity, length of sickness, work conditions, marital status, and
drinking habits. (The frequency of drinking outside the home and
the frequency of physical exercise are included as variations only
between t and t – 2 because they are recorded only biannually in
the BHPS.)
Last, a full set of time-variant variables related to health
shocks, which previous literature has demonstrated affects quit-
ting smoking (see, e.g., Clark and Etilé [26]), was included,
reporting both absolute levels and variations between t and t –
1 and between t – 1 and t – 2, for self-assessed health, visits to
general practitioner, visits to outpatient departments, serious
accidents, and health problems. Time-variant covariates were
used to control for the effect of various lifestyle shocks, mostly
health-related, which may also have had an effect on the
decision to quit smoking and also on weight. In addition, the
dummy variables recording whether subjects were underweight,
normal weight, overweight, or obese in 2004 and a full set of
interactions with the time dummy were included to account for
differing BMI dynamics. These covariates are included as proxies
of health concerns or orientation toward the future of individuals
with different initial conditions in terms of BMI. Summary
statistics of covariates for the treated (TGQ) and control groups
are listed in Table 1 and Appendix A.1 in Supplemental Materials
found at http://dx.doi.org/10.1016/j.jval.2015.06.008.Results
Preliminary Analysis
Table 2 presents an average BMI increase of 0.85 points for TGQ
and a smaller variation for CGS (0.24 BMI points). The uncondi-
tional ATE, according to these two groups, is therefore estimated
to be 0.61 BMI points. According to other control groups, the
estimated ATE is about 0.6 BMI points, except for CG08, in which
it is slightly larger. We also used the usual BMI clinical thresholds
to calculate unconditional ATEs for underweight, normal-weight,
overweight, and obese individuals. Table 3 shows that the effect
of quitting smoking on BMI is greater for obese individuals (range
0.97–1.08 points), irrespective of the control group used.
Main Estimates
Table 4 lists ordinary least squares estimates in which smokers
are assumed to be the control group (CGS). For the reference
category (normal-weight individuals, h ¼ 2), we estimated an
effect of quitting smoking on BMI of 0.31 (standard error [SE] ¼
0.122) and this coefﬁcient was found to increase for individuals in
the higher BMI clinical categories. For overweight individuals (h ¼
3), quitting smoking produced an extra BMI increase, with respect
to the effect for the reference category, of 0.48 points (SE ¼ 0.214),
so that the total BMI increase for these individuals was 0.79.
When we interacted the treatment with the obese category, wealso found a positive and signiﬁcant coefﬁcient of 0.75 (SE ¼
0.384), implying a total BMI variation of 1.06 points. Last, under-
weight people presented a nonsigniﬁcant coefﬁcient, meaning
that their BMI variation after quitting was not statistically differ-
ent from that of normal-weight people.
When we examined the δ coefﬁcients, we found a positive
and signiﬁcant variation of 0.36 (SE ¼ 0.065) for normal-weight
people. Overweight and obese individuals showed lower trends
with respect to the reference category, –0.20 (SE ¼ 0.079) and –
0.71 (SE ¼ 0.14), respectively. To calculate the trends for the two
categories, the effects estimated through the interaction terms
had to be added to the parameter of the reference category.
That is, the BMI of overweight and obese individuals varied by
0.16 and –0.35 points, respectively, between 2004 and 2006,
consistent with the results from descriptive statistics presented
in Table 2.
Table 4 also lists the estimated parameters from other control
groups. When CGNS and CGALL were used as alternative control
groups, the resulting ATEs were lower, but not very distant from
those obtained from our baseline model. Last, we also show the
estimates with CG08 as the control group. Although the ATE was
in line with our expectations in terms of magnitude, it was not
statistically different from zero. The small size of the obese
subsample when CG08 was used as the control group, however,
does not allow us to make accurate inferences. (With CG08 as the
control group, there were 78 obese individuals per year and 102 in
CGS, for a total of 180 obese individuals in the sample used to
estimate the effect of quitting on BMI.)
Social Costs and Beneﬁts
Our estimates identiﬁed the robust negative causal effect of
smoking on body weight, which was larger in magnitude for
overweight and obese people. This result is of crucial importance
in the health economic literature because policymakers are
interested in understanding whether the beneﬁts from savings
deriving from reduced smoking are larger or smaller than the
extra costs generated by increased obesity.
Panel A of Table 5 shows the NHS costs associated with
smoking in 2006, estimated by Allender et al. [14] to be £5170
million for the United Kingdom in 2006. Because 22% of the UK
population smoked in 2006 (60,587,600), we can calculate a per-
capita cost of smoking of £388. In addition, using the estimated
total direct cost attributable to obesity of £3532 million in 2002
[15,16] and considering that the obese represented 24% of the
total UK population in 2006, we obtained a per-capita cost of
obesity of £2441. (To make costs comparable, the costs attribut-
able to obesity in 2002 were divided by the consumer price index
excluding tobacco, at base year 2002, provided by the NHS ofﬁcial
statistics on price index data. The costs associated with smoking
had already been estimated in 2006 pounds.)
Panel B of Table 5 lists the beneﬁts of reduced smoking and
the costs of the resulting increased obesity. From the BHPS, we
can estimate that 2.75% of the smokers who were also classiﬁed
as obese in 2004 quit smoking in 2006, and so this percentage can
be used to calculate that the direct social beneﬁts, in terms of
NHS cost reductions attributable to smoking, were £156.81 mil-
lion. This ﬁgure was obtained by multiplying the number of obese
individuals who quit smoking (i.e., 400,000, 2.75% of 14.54 million
obese individuals in 2004) by the per-capita cost of smoking
(£388).
We also calculated the estimated social costs associated
with increased obesity, attributable to quitting smoking. They
arise from two different sources: 1) the extra costs of having to
treat even those individuals who were overweight in 2004 and
who, because of smoking-related weight increases, became
obese in 2006; 2) the “lost beneﬁts” of having to treat those
Table 1 – Descriptive statistics of covariates.
Variable TGQ CGS CGNS CGALL CG08
2004 2006 2004 2006 2004 2006 2004 2006 2004 2006
Time-invariant covariates
Sex
Male 0.48 0.49 0.45 0.46 0.45 0.46 0.45 0.46 0.43 0.43
Female 0.52 0.51 0.55 0.54 0.55 0.54 0.55 0.54 0.57 0.57
Age class (y)
18–29 0.27 0.23 0.23 0.23 0.14 0.13 0.17 0.16 0.26 0.22
30–39 0.25 0.25 0.24 0.22 0.18 0.16 0.19 0.17 0.24 0.24
40–49 0.14 0.17 0.2 0.22 0.19 0.2 0.2 0.2 0.21 0.22
50–59 0.13 0.12 0.17 0.17 0.18 0.17 0.18 0.17 0.13 0.15
60þ 0.21 0.23 0.16 0.17 0.31 0.34 0.27 0.29 0.15 0.17
Ethnic group
White 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99
Other 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Education
Degree 0.13 0.13 0.07 0.07 0.16 0.17 0.14 0.14 0.08 0.1
Diploma 0.25 0.27 0.24 0.27 0.29 0.3 0.27 0.29 0.29 0.31
A-level 0.11 0.1 0.11 0.11 0.12 0.11 0.12 0.11 0.13 0.12
O-level 0.19 0.17 0.2 0.18 0.16 0.14 0.17 0.15 0.16 0.15
Low educated 0.32 0.33 0.38 0.37 0.28 0.29 0.31 0.31 0.33 0.32
Net income
First quintile 0.23 0.19 0.27 0.26 0.2 0.17 0.22 0.19 0.24 0.21
Second quintile 0.18 0.21 0.22 0.23 0.19 0.19 0.2 0.2 0.21 0.24
Third quintile 0.23 0.21 0.22 0.2 0.21 0.19 0.21 0.19 0.22 0.17
Fourth quintile 0.21 0.2 0.17 0.17 0.21 0.21 0.19 0.2 0.21 0.23
Fifth quintile 0.15 0.19 0.12 0.14 0.2 0.23 0.18 0.21 0.12 0.16
Country
England 0.53 0.54 0.45 0.44 0.49 0.5 0.48 0.48 0.46 0.46
Wales 0.15 0.15 0.17 0.18 0.17 0.17 0.17 0.17 0.17 0.16
Scotland 0.17 0.16 0.19 0.19 0.17 0.17 0.17 0.18 0.19 0.2
Northern Ireland 0.15 0.15 0.18 0.19 0.17 0.16 0.17 0.17 0.18 0.18
Time-variant covariates
Marital status
Married 0.47 0.51 0.42 0.43 0.61 0.62 0.56 0.57 0.44 0.47
Separated 0.03 0.02 0.04 0.04 0.02 0.02 0.02 0.02 0.04 0.03
Divorced 0.1 0.1 0.13 0.13 0.07 0.07 0.08 0.09 0.1 0.13
Widowed 0.04 0.05 0.05 0.06 0.09 0.1 0.08 0.09 0.05 0.05
Never married 0.35 0.31 0.36 0.35 0.22 0.2 0.26 0.24 0.37 0.32
Variations on marital status
Married in t 0.03 0.03 0.03 0.03 0.01 0.02 0.02 0.02 0.02 0.03
Married in t – 1 0.03 0.03 0.02 0.02 0.01 0.02 0.02 0.02 0.02 0.03
Separated in t 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01
Separated in t – 1 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01
Divorced in t 0.02 0.02 0.01 0.02 0.01 0.01 0.01 0.01 0.02 0.02
Divorced in t – 1 0.02 0.02 0.01 0.02 0.01 0.01 0.01 0.01 0.02 0.02
Widowed in t 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Widowed in t – 1 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Strenuous job
Yes 0.04 0.06 0.05 0.05 0.04 0.04 0.04 0.04 0.07 0.06
No 0.96 0.94 0.95 0.95 0.96 0.96 0.96 0.96 0.93 0.94
Variations on job strenuousness
From strenuous to nonstrenuous
in t
0.04 0.05 0.05 0.04 0.03 0.04 0.04 0.04 0.05 0.02
From nonstrenuous to strenuous
in t
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02
From strenuous to nonstrenuous
in t – 1
0.06 0.06 0.05 0.04 0.04 0.04 0.04 0.04 0.05 0.03
From nonstrenuous to strenuous
in t – 1
0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01
Drinking habits
At least once a week 0.36 0.28 0.35 0.34 0.24 0.23 0.27 0.26 0.35 0.33
Less than once a week 0.64 0.72 0.65 0.66 0.76 0.77 0.73 0.74 0.65 0.67
continued on next page
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Table 1 – continued.
Variable TGQ CGS CGNS CGALL CG08
2004 2006 2004 2006 2004 2006 2004 2006 2004 2006
Variation on drinking habits
From less than once to once a
week between t and t – 2
0.11 0.07 0.11 0.09 0.11 0.06 0.09 0.07 0.14 0.07
From once to less than once a
week between t and t – 2
0.09 0.09 0.09 0.09 0.07 0.07 0.07 0.08 0.11 0.09
Physical activity
At least once a week 0.50 0.51 0.51 0.52 0.54 0.56 0.52 0.54 0.50 0.51
Less than once a week 0.50 0.49 0.49 0.48 0.46 0.44 0.48 0.46 0.50 0.49
Variation on drinking habits
From less than once to once a
week between t and t – 2
0.04 0.05 0.07 0.05 0.09 0.06 0.08 0.06 0.04 0.06
From once to less than once a
week between t and t – 2
0.03 0.06 0.04 0.06 0.05 0.03 0.04 0.03 0.03 0.05
Long-term sickness
Yes 0.06 0.06 0.08 0.09 0.03 0.03 0.05 0.05 0.07 0.05
No 0.94 0.94 0.92 0.91 0.97 0.97 0.95 0.95 0.93 0.95
Variation on long-term sickness
From non–long-term to long-term
sick in t
0.08 0.07 0.06 0.08 0.02 0.06 0.04 0.06 0.06 0.05
From long-term to non–long-term
sick in t
0.01 0.01 0.02 0.02 0.01 0.01 0.01 0.01 0.02 0.02
From non–long-term to long-term
sick in t – 1
0.07 0.04 0.06 0.05 0.07 0.03 0.05 0.04 0.05 0.03
From long-term to non–long-term
sick in t – 1
0.01 0.01 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.02
Working women in household
Yes 0.91 0.77 0.9 0.78 0.91 0.69 0.91 0.72 0.91 0.82
No 0.09 0.23 0.1 0.22 0.09 0.31 0.09 0.28 0.09 0.18
Variation on number of working women in household
Between t and t – 1 –0.01 –0.14 –0.01 –0.11 –0.01 –0.22 –0.01 –0.19 –0.01 –0.09
Between t – 1 and t – 2 0 0 0 0 0 0 0 0 –0.01 0.01
Job hours (including overtime)
Number 30.86 29.05 28.51 28.26 27.42 26.96 27.72 27.29 29.68 30.19
Variation on job hours (including overtime)
Between t and t – 1 –0.34 –0.77 0.08 –0.22 0.07 –0.24 0.07 –0.23 –0.53 –0.8
Between t – 1 and t – 2 0.64 –1.12 –0.02 0.15 –0.13 –0.32 –0.1 –0.2 –0.01 1.31
Note. A-levels and O-levels refer to the examinations for the General Certiﬁcate of Education offered by educational institutions in the United
Kingdom and a few of the former British colonies. In particular, A-levels were the subsequent examinations for those who studied for a further
2 years after O-levels at the age of 16 y.
CGALL, control group of smokers and nonsmokers; CGNS, control group of nonsmokers; CGS, control group of smokers; CG08, control group of
“next period” quitters; TGQ, treated groups of quitters.
Table 2 – BMI absolute variations and ATEs (2004–2006) by smoking status group.
Groups No. of observations BMI Absolute variation ATE
2004 2006 (2004–2006) (2004–2006)
TGQ 491 25.04 25.89 0.85 –
CGS 3261 25.11 25.36 0.25 0.6
CGALL 11924 25.76 26.04 0.28 0.57
CGNS 8663 26.02 26.24 0.22 0.63
CG08 385 24.6 24.78 0.18 0.67
ATE, average treatment effect; BMI, body mass index; CGALL, control group of smokers and nonsmokers; CGNS, control group of nonsmokers;
CGS, control group of smokers; CG08, control group of “next period” quitters; TGQ, treated groups of quitters.
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Table 3 – BMI absolute variations and ATEs (2004–2006) by smoking status group and BMI class.
BMI class Absolute variation ATE
o19 19–25 25–30 430 o19 19–25 25–30 430
TGQ 1.13 0.71 1 0.78 – – –
CGS 0.35 0.41 0.2 –0.3 0.81 0.3 0.8 1.09
CGALL 0.38 0.42 0.21 –0.21 0.73 0.27 0.75 0.97
CGNS 0.44 0.41 0.24 –0.18 0.72 0.29 0.75 0.98
CG08 0.41 0.36 –0.01 –0.20 0.76 0.33 1.01 0.99
Note. BMI clinical classes: o19, underweight; 19–25 normal weight; 25–30, overweight; 430, obese.
ATE, XXX; BMI, body mass index; CGALL, control group of smokers and nonsmokers; CGNS, control group of nonsmokers; CGS, control group of
smokers; CG08, control group of “next period” quitters; TGQ, treated groups of quitters.
V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 7 9 1 – 7 9 9 797individuals who were already obese in 2004 and who, because
they stopped smoking, did not become overweight in 2006.
From our empirical model, the BMI in 2006 is a linear function of
two components, δþβ1, all other characteristics remaining
constant. The estimates of Equation 1 (Table 3) show the effectTable 4 – Causal effect of quitting smoking on BMI by cli
Parameter CGS CG
η1 –0.09
(0.114)
–0
(0.
η1,1 0.14 –0
(0.278) (0.
η1,3 –0.15 0
(0.176) (0.
η1,4 –0.41 0
(0.417) (0.
β1 0.26
‡ 0.
(0.135) (0.
β1,1 0.44 0
(0.484) (0.
β1,3 0.49
† 0.
(0.228) (0.
β1,4 0.76
‡ 0.
(0.396) (0.
δ 0.42* 0.
(0.053) (0.
δ1 –0.08 0
(0.107) (0.
δ3 –0.21
† –0
(0.084) (0.
δ4 –0.72
* –0
(0.158) (0.
Constant 22.93* 22
(0.228) (0.
Observations 5,361 15
R2 0.80 0
Adjusted R2 0.80 0
Notes. h = 1, 2, 3, 4 represents BMI clinical classes of underweight, norm
modalit y. The estimated parameters are those described in Equation 1:
BMIit¼μþ
X4
h¼1
ηhðD BÞihþ
X4
h¼1
δhðT  BÞthþ
X4
h¼1
βhðD T  BÞithþ
XJ
j¼1
πjXjitþεi,
Standard errors are given in parentheses.
BMI, body mass index; CGALL, control group of smokers and nonsmokers
CG08, control group of “next period” quitters; TGQ, treated groups of qu
* P r 0.01.
† P r 0.05.
‡ P r 0.1.of quitting smoking on BMI of overweight individuals in 2004,
which is β1þβ1;3¼0:75. To exclude those individuals who would
have become obese because of other factors, we must add to
this value the estimated BMI growth trend, represented by δþδ3,
of 0.21. In other words, our model predicts that overweightnical classes and control group.
NS CGALL CG08
.30*
107)
–0.23†
(0.105)
0.01
(0.161)
.11 0.01 –0.26
266) (0.260) (0.358)
.02 –0.03 0.13
167) (0.164) (0.241)
.07 –0.04 0.75
394) (0.391) (0.512)
30† 0.29† 0.25
125) (0.124) (0.199)
.39 0.43 0.48
475) (0.472) (0.536)
43† 0.44† 0.73†
216) (0.214) (0.327)
65‡ 0.66‡ 0.13
355) (0.357) (0.629)
44* 0.42* 0.43*
029) (0.026) (0.151)
.06 0.00 0.01
085) (0.065) (0.255)
.17* –0.18* –0.45‡
042) (0.038) (0.243)
.61* –0.62* –0.20
067) (0.062) (0.503)
.78* 22.80* 22.84*
136) (0.118) (0.468)
,200 19,741 1,540
.80 0.80 0.78
.80 0.80 0.77
al weight, overweight, and obesity. Normal weight is the reference
t ð1Þ
; CGNS, control group of nonsmokers; CGS, control group of smokers;
itters.
Table 5 – Social costs and beneﬁts of quitting
smoking.
A.
UK population 60.59 million
Percentage of smokers 0.22
Cost of smoking (£) 5170.5 million
Percentage of overweight people 0.38
Percentage of obese people 0.24
Cost of obesity (£) 3550.4 million
Per-capita cost of smoking (£) 387.91
Per-capita cost of obesity (£) 244.1
Social beneﬁts of quitting smoking (£) 156.81 million
B.
(δ þ δ3) þ (β1 þ β1,3), CGS 0.21 þ 0.75
(δ þ δ4) þ (β1 þ β1,4), CGS –0.30 þ 1.02
Obese quitters between 2004 and 2006
(estimated by BHPS) (%)
0.0275
Percentage of overweight individuals with a
BMI of 429.05 and o29.85
4.23
Percentage of obese individuals with a BMI
of o30.35 and 430
1.69
Social costs of increased obesity: overweight
with a BMI of 429.05 and o29.85 (£)
17.20 million
Social costs of increased obesity: obese with
a BMI of o30.35 (£)
6.87 million
Net social beneﬁts of quitting smoking (£) 132.74 million
Notes. All values were calculated in 2006 pounds divided by the
corresponding consumer price index with base year in 2002,
provided by NHS ofﬁcial statistics on price indices data.
BMI, body mass index; CGS, control group of smokers; BHPS,
British Household Panel Survey; NHS, National Health Service.
V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 7 9 1 – 7 9 9798smokers who quit smoking and had a BMI of more than 29.04
(buto29.84) in 2004 would become obese in 2006 (BMI of430 in
2006) because of quitting. This quota of individuals represents
an extra cost that the NHS would not have sustained in a
scenario in which nobody quits.
In addition, again looking at Table 4, our estimates indicate
a negative trend for obese people (δþδ4¼0:30), implying that
those who had a BMI of more than 30 but lower than 30.30 in
2004 would become overweight in 2006 and would not repre-
sent a cost (at least in terms of obesity) for the NHS. But, if we
look at the obese individuals who also quit smoking in 2006,
the positive effect associated with quitting, β1þβ1;4¼1:02,
clearly overcompensates the natural decreasing trend of
BMI and keeps a signiﬁcant number of individuals trapped
in obesity. These people represent a lost beneﬁt for the NHS
in terms of savings due to reduced obesity. All the other
individuals classiﬁed as obese in 2006 would have been obese
in any case, and consequently are not considered a burden for
the NHS.
Again, panel B of Table 5 presents the estimates of the costs
described previously. The percentage of individuals with a BMI of
more than 29.04 and less than 29.80 in 2004, estimated by the
BHPS, was 4.23% of the total population (i.e., 2.56 million people).
If we assume that 2.75% of the UK population (i.e., a sample of
70,481) quit smoking in 2006, we obtain an additional cost of
£17.20 million (70,481  £2,441) for the NHS. Moreover, the
percentage of individuals with a BMI of more than 30 and less
than 30.30 in 2004 was 1.69% (i.e., 1024 million people). Also, in
this case, we assume that 2.75% (i.e., 28,159 people) quit smoking
and estimate a lost beneﬁt of £6.87 million (28,159  £2,441). Last,
the net beneﬁt of £132.74 million is estimated by subtracting
these costs from the total beneﬁt.Conclusions
In this study, our estimates support the ﬁnding that quitting
smoking inﬂuences weight gains in the United Kingdom. Regres-
sions that account for the usual clinical thresholds also reveal a
greater sensitivity of quitting on people in obesity status. In other
important differences, our estimates reveal that the coefﬁcients
between smoking and body weight in the control groups are close
to each other, excluding any signiﬁcant upward or downward
estimation bias of this relationship.
These ﬁndings add new evidence to the debate on antismoking
policies and related beneﬁts to decrease the number of potential
smokers in the United Kingdom. We show that the reduction in
smokers has signiﬁcant, although limited, effects on weight gains,
which are slightly larger in overweight and obese people.
From the economic perspective, our results indicate that the
substantial health beneﬁts in stopping smoking do not play a role
in increasing the cost of overweight and obesity. Prudent esti-
mates from a social cost-beneﬁt analysis suggest larger savings in
health costs from quitting smoking than the costs associated
with increased obesity.Acknowledgments
This article is based on work carried out during a visit to the
European Centre for Analysis in the Social Sciences at the
Institute for Social and Economic Research, University of Essex,
supported by the “Access to Research Infrastructures Action
under the EU Improving Human Potential Programme.”
Data from the British Household Panel Survey were supplied
by the UK Data Archive. Neither the original collectors of the data
nor archive personnel have any responsibility for the analyses or
interpretations presented here.
We thank Amanda Kowalski and the participants in the “4th
Annual Health Econometrics Workshop” at Hunter College of The
City University of New York for their valuable comments and
suggestions.
Source of ﬁnancial support: This work has been supported by
a grant from the Public Health Department of the Umbria Region.Supplemental Materials
Supplemental materials accompanying this article can be found
in the online version as hyperlink at http://dx.doi.org/10.1016/j.
jval.2015.06.008 or, if a hard copy of article, at www.valueinhealth
journal.com/issues (select volume, issue, and article).
R E F E R E N C E S[1] Brunello G, Michaud PC, de Galdeano AS. The rise of obesity in Europe:
an economic perspective. Econ Pol 2009;24:551–96.
[2] Chou SY, Grossman M, Saffer H. An economic analysis of adult obesity:
results from the behavioral risk factor surveillance system. J Health
Econ 2004;23:565–87.
[3] Gruber J, Frakes M. Does falling smoking lead to rising obesity? J Health
Econ 2006;25:183–97.
[4] Flegal K. The effects of changes in smoking prevalence on obesity
prevalence in the United States. Am J Pub Health 2007;97:1510–4.
[5] Nonnemaker J, Finkelstein E, Engelen M, et al. Have efforts to reduce
smoking really contributed to the obesity epidemic? Econ Inq 2009;47:366–76.
[6] Baum CL. The effects of cigarette costs on BMI and obesity. Health Econ
2009;18:3–19.
[7] Courtemanche C. Rising cigarette prices and rising obesity: coincidence
or unintended consequence? J Health Econ 2009;28:781–98.
V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 7 9 1 – 7 9 9 799[8] Liu F, Zhang N, Cheng KW, Wang H. Reduced smoking and rising
obesity: does smoking ban in the workplace matter? Econ Lett
2010;108:249–52.
[9] Wehby GL, Courtemanche CJ. The heterogeneity of the cigarette price
effect on body mass index. J Health Econ 2012;31:719–29.
[10] Pieroni L, Salmasi L. Does cigarette smoking affect body weight? Causal
estimates from the clean indoor air law discontinuity. Economica 2015.
In Press.
[11] Grunberg N. Nicotine, cigarette smoking, and body weight. Br J Addict
1985;80:369–77.
[12] Klesges R, Meyers A, Klesges L, LaVasque M. Smoking, body weight, and
their effects on smoking behavior: a comprehensive review of the
literature. Psychol Bull 1989;106:204–30.
[13] French S, Jeffery R. Weight concerns and smoking: a literature review.
Ann Behav Med 1995;17:234–44.
[14] Allender S, Balakrishnan R, Scarborough P, et al. The burden of
smoking-related ill health in the UK. Tob Control 2009;18:262–7.
[15] The House of Commons Health Select Committee. Obesity: Third
Report of Session 2003/2004. The Stationery Ofﬁce: London, 2004.
[16] McCormick B, Stone I. Economic costs of obesity and the case for
government intervention. Obesity Rev 2008;8(Suppl.1):161–4.[17] Morris S. Body mass index and occupational attainment. J Health Econ
2006;25:347–64.
[18] Shiely F, Hayes K, Perry IJ, Kelleher CC. Height and weight bias: the
inﬂuence of time. PLOS One 2013;8:1–8.
[19] Becker GS, Murphy KM. A theory of rational addiction. J Pol Econ
1988;96:675–700.
[20] Baltagi BH, Grifﬁn JM. The econometrics of rational addiction: the case
of cigarettes. J Bus Econ Stat 2001;19:449–54.
[21] French MT, Norton EC, Fang H, Maclean JC. Alcohol consumption and
body weight. Health Econ 2010;19:814–32.
[22] West R, Sohal T. “Catastrophic” pathways to smoking cessation:
ﬁndings from a national survey. BMJ 2006;332:458–60.
[23] Cawley J, Markowitz S, Tauras J. Lighting up and slimming down: the
effects of body weight and cigarette prices on adolescent smoking
initiation. J Health Econ 2004;23:293–311.
[24] McCaul KD, Hockemeyer JR, Johnson RJ, et al. Motivation to quit using
cigarettes: a review. Addict Behav 2006;31:42–56.
[25] Del Bono E, Vuri D. Job mobility and the gender wage gap in Italy.
Labour Econ 2011;18:130–42.
[26] Clark A, Etilé F. Do health changes affect smoking? Evidence from
British panel data. J Health Econ 2002;21:533–62.
